P17

General Information


DRACP ID  DRACP01101

Peptide Name   P17

Sequence  YQEPVLGPVRGPFPIIV

Sequence Length  17

UniProt ID  Q9TSI0  P02666 

PubChem CID  Not available

Origin  Synbiotic yoghurt

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HT-29 Colon adenocarcinoma Carcinoma Antiproliferative acitivity (%)=41.49±2.18%,  Peptide concentration 3 mg/mL MTS assay 72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01101

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C91H141N21O22

Absent amino acids  ACDHKMNSTW

Common amino acids  P

Mass  216681

Pl  6.4

Basic residues  1

Acidic residues  1

Hydrophobic residues  7

Net charge  0

Boman Index  433

Hydrophobicity  48.24

Aliphatic Index  120

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  93.13

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Antioxidant peptides isolated from synbiotic yoghurt exhibit antiproliferative activities against HT-29 colon cancer cells

Doi 10.1016/j.idairyj.2016.08.003

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.